Exclusive: Private equity firms circling Nestle's skin health business - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Johnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital
January 23, 2019 6:53 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.
Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.
... More